Product Teva-Pregabalin 150 mg capsules Issue Health products - Contamination What to do If you experience a serious allergic reaction (anaphylaxis), stop taking the affected product and seek immediate medical help by calling 9-1-1. Otherwise, do not stop taking your pregabalin medication without first speaking with your healthcare professional or pharmacist, as stopping suddenly may cause withdrawal symptoms. Return the product to the pharmacy where it was purchased as soon as possible for a replacement or alternative supply, and for proper disposal. If you are unsure whether your product is recalled, check with your pharmacy. Distribution National
Hazard description
Teva Canada Ltd. is recalling two lots of Teva-Pregabalin 150 mg capsules after routine testing identified that some capsules may be contaminated with the drug sertraline. Patients with a hypersensitivity or allergy to sertraline could experience side effects or have a serious allergic reaction, including an anaphylactic reaction, even at a low exposure.Anaphylactic reaction symptoms can be fatal and may include:Shortness of breath, wheezing, or difficulty breathingSwelling of the eyelids, face, lips, mouth, tongue, or throatUncontrolled shakingFainting or dizzinessTrouble swallowing or speakingWidespread rash, hivesProducts from the recalled lots were first sold in Canada in September 2025 and expire July 31, 2027.Pregabalin is a prescription drug used in adults to treat pain caused by nerve damage due to diabetes, shingles or spinal cord injury. It is also used to treat pain associated with fibromyalgia.Sertraline is a prescription drug used in adults to relieve symptoms of depression, obsessive-compulsive disorder, and panic disorder. Side effects may include nausea, diarrhea, dry mouth, sleep changes, dizziness, tremors or increased sweating.Health Canada is monitoring the company's recall and implementation of corrective and preventive actions.